Group IVE cytosolic phospholipase A 2 limits psoriatic inflammation by mobilizing the anti‐inflammatory lipid N ‐acylethanolamine
- 28 April 2022
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 36 (5) , e22301
Abstract
Psoriasis is an inflammatory disorder characterized by keratinocyte hyper‐proliferation and Th17‐type immune responses. However, the roles of bioactive lipids and the regulation of their biosynthesis in this chronic skin disease are not fully understood. Herein, we show that group IVE cytosolic phospholipase A 2 (cPLA 2 ε/PLA2G4E) plays a counterregulatory role against psoriatic inflammation by producing the anti‐inflammatory lipid N ‐acylethanolamine (NAE). Lipidomics analysis of mouse skin revealed that NAE species and their precursors ( N ‐acyl‐phosphatidylethanolamine and glycerophospho‐ N ‐acylethanolamine) were robustly increased in parallel with the ongoing process of imiquimod (IMQ)‐induced psoriasis, accompanied by a marked upregulation of cPLA 2 ε in epidermal keratinocytes. Genetic deletion of cPLA 2 ε exacerbated IMQ‐induced ear swelling and psoriatic marker expression, with a dramatic reduction of NAE‐related lipids in IMQ‐treated, and even normal, skin. Stimulation of cultured human keratinocytes with psoriatic cytokines concomitantly increased PLA2G4E expression and NAE production, and supplementation with NAEs significantly attenuated the cytokine‐induced upregulation of the psoriatic marker S100A9 . Increased expression of cPLA 2 ε was also evident in the epidermis of psoriatic patients. These findings reveal for the first time the in vivo role of cPLA 2 ε, which is highly induced in the keratinocytes of the psoriatic skin, promotes the biosynthesis of NAE‐related lipids, and contributes to limiting psoriatic inflammation.Keywords
Funding Information
- Japan Agency for Medical Research and Development (18gm0710006, 20gm1210013, 20gm4010005, 20ek0410052, 20gm0910002)
- Hoyu Science Foundation
This publication has 80 references indexed in Scilit:
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- Efficient genome editing in zebrafish using a CRISPR-Cas systemNature Biotechnology, 2013
- Regulation of Peroxisomal Lipid Metabolism by Catalytic Activity of Tumor Suppressor H-rev107Journal of Biological Chemistry, 2012
- TIM23‐mediated insertion of transmembrane α‐helices into the mitochondrial inner membraneThe EMBO Journal, 2011
- Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-β1 Transgenic MiceThe American Journal of Pathology, 2011
- Interfacial Kinetic and Binding Properties of Mammalian Group IVB Phospholipase A2 (cPLA2β) and Comparison with the Other cPLA2 IsoformsJournal of Biological Chemistry, 2010
- Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of strokeNeuroscience, 2010
- The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunitiesTrends in Pharmacological Sciences, 2009
- Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for PruritusThe Journal of Pharmacology and Experimental Therapeutics, 2009
- N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: A novel enzyme of the β-lactamase fold family releasing anandamide and other N-acylethanolaminesLife Sciences, 2005